Klinik fanlar yilnomasi 3-tom 2-san (2026)
EFFECT OF AN OPTIMIZED TREATMENT REGIMEN ON THE DYNAMICS OF FETUIN-A, TLR4 AND INFLAMMATION BIOMARKERS IN RHEUMATOID ARTHRITIS
Каримов М.Ш, Шукурова Ф.Н, Норматова К.Ш
Annotaciya
This article discusses the influence of an optimized complex treatment regimen on serum levels of Fetuin-A, Toll-like receptor 4 (TLR4) and systemic inflammation biomarkers (IL-1β, IL-6, TNF-α, anti-CCP) in patients with rheumatoid arthritis (RA). The study was conducted in 2024-2026 at the Rheumatology Department of the National Medical Center. A total of 140 patients with confirmed RA based on EULAR/ACR-2010 criteria and 36 practically healthy individuals were enrolled. The patients were divided into four subgroups according to the clinical form of the disease and type of therapy. The results of the 12-week follow-up demonstrated that the optimized complex regimen restores Fetuin-A levels, reduces TLR4 expression, decreases IL-1β, IL-6, TNF-α and anti-CCP concentrations by 2.5-3.5 times compared with the conventional scheme, and improves clinical efficacy according to EULAR/ACR response criteria. The most pronounced positive response was registered in patients with the extra-articular clinical form of the disease.
rheumatoid arthritis, Fetuin-A, TLR4, systemic inflammation, ademetionine, EULAR/ACR response, optimized regimenревматоидный артрит, Фетуин-А, TLR4, системное воспаление, адеметионин, ответ по EULAR/ACR, усовершенствованная схемаревматоид артрит, Фетуин-А, TLR4, тизимли яллиғланиш, адеметионин, EULAR/ACR жавоб, такомиллаштирилган даво
Metadata derekkózi: jurnal OAI-PMH arxivi · Sindex tolıq mátindi saqlamaydı, derekkózge silteme beredi.